Spotify and Universals AI Music Deal Creates New Paywall for FanMade Covers and Remixes Ferrari Shares Slip After Unveiling Luce Its First AllElectric Model Political Scandal Over Film Funding Casts Doubt on Flvio Bolsonaros Presidential Campaign Microsoft Shares Feel the Heat Amid SaaSmaggedon Selloff in Cloud Software Sector Analyst Report Update SP Global Inc Market Position and Segment Outlook Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project Dolphin Entertainment Inc DLPN Q1 2026 Earnings EPS Falls Short of Estimates by Wide Margin Revenue Not Disclosed LeonaBio Inc LONA Q1 2026 Earnings Narrowing Losses Signal Operational Discipline Revvity Q1 2026 Earnings Solid EPS Beat Amidst Cost Discipline Senmiao Technology Limited AIHS Q1 2026 Earnings Loss Deepens Amid Ongoing Operational Challenges RSG Q1 2026 Earnings Earnings Beat Estimates Amid Solid Operational Execution PENN Q1 2026 Earnings EPS Misses Estimates as Margins Remain Under Pressure Donegal Group Inc DGICA Shows Modest Decline as Trading Holds Within Key Range Western Asset Investment Grade Opportunity Trust IGI Holds Steady Near Key Support Resistance Ahead Infinity Natural Resources INR Holds Steady Near Support Targets Resistance Breakout Puma Biotechnology PBYI Edges Higher Amidst Key Support and Resistance Levels Johnson Johnson JNJ Edges Higher as Defensive Appeal Strengthens Palantir Technologies Assessing Potential for Growth in the AI Sector American Integrity Insurance Director Smathers Acquires 49270 in Company Stock Arabica Coffee Prices Surge to Record on USColombia Trade Developments BPs Abrupt Chairman Removal Linked to Alleged Bullying Behavior Company Declines Comment Pfizer Wins Singapore Trademark Dispute with Merck Over Vaccine Brand Samsungs Latest Labor Deal May Set Precedent for Bonus Negotiations Across South Korean Industries Titan Company Poised to Lead Indias Formalizing Gold Market as Consumer Demand Shifts to Investment VTGN Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Advances Aurinia Pharmaceuticals AUPH Treads at 1522 as Shares Dip Support and Resistance in Focus